Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
Status
RECRUITING
Phase
NA
Age
55 - 85 Years
Enrollments
20Conditions
Localized Prostate Carcinoma, Locally Advanced Prostate Carcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8Summary
This clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors. Golf is a multimodal recreational activity that requires participants to utilize all muscle groups to perform the golf swing, walk over hilly and uneven terrain, maintain balance during putting and squat-like tasks. Physical activity and exercise are beneficial to physical function, cognitive function, psychosocial health, and overall quality of life during prostate cancer survivorship. These aspects of health are impacted by prostate cancer treatment, especially androgen deprivation therapy. Additionally, supervised, group-based activity programs facilitate participation in physical activity. Researchers want to examine the changes in functional abilities, psychosocial health, and quality of life following participation in in a golf program designed for prostate cancer survivors.
Detailed Description
PRIMARY OBJECTIVES:
I. To recruit, screen, and enroll prostate cancer survivors. II. To examine the safety, feasibility, and adherence, of the 10-week (wk) GREENS program.
III. To analyze the pre-post intervention data and examine the effects (assessed by Hedges g) of the program on:
IIIa. Physical capacity; IIIb. Psychosocial wellness; IIIc. Health, and; IIId. Cognition.
OUTLINE:
Patients participate in the golf training program composed of group sessions over 1-2 hours with a Professional Golfers’ Association of America (PGA) professional two times per week for ten weeks. Training consists of complimentary/warm up exercises integrated with pelvic floor muscle training, golf instruction, golf practice, and golf play on a Par 3 public golf course. Patients also wear an activity tracker and undergo blood sample collection on the study.
After completion of study intervention, patients are followed up at 6 months.
Locations
2 locations Found with status Recruiting
Status
- RECRUITING
Contact Person
- George Salem, PhD
- 323-442-3113
- [email protected]
Principal Investigator
- George Salem, PhD
Status
- RECRUITING
Contact Person
- George Salem, PhD
- 323-442-3113
- [email protected]
Principal Investigator
- George Salem, PhD
Eligibility Criteria
Inclusion Criteria:
* First time, primary diagnosis of prostate cancer (PCa)
* Currently receiving androgen deprivation therapy (ADT) and/or androgen receptor blocker) for more than 6 months
* Older adult male: 55-85 years old
* The ability to stand independently without external support
* No or minimal golf experience (played < 5 times in the past 10 years)
* English speaking
Exclusion Criteria:
* Second cancer diagnosis (excluding non-invasive skin cancers) or bone metastases
* Prostatectomy less than 6 months prior to study enrollment (prostatectomy is not a requirement for study entry)
* Symptomatic cardiovascular disease, active angina, uncontrolled hypertension (systolic blood pressure (SBP) > 160 or diastolic blood pressure (DBP) > 90, high resting pulse heart rate (HR) > 90), symptomatic orthostatic hypotension
* Unstable asthma, exacerbated chronic obstructive pulmonary disease (COPD]
* History of injury or orthopedic operation within the last 6 months
* Movement disorders (e.g., Parkinson's disease (PD) or other neurological disorders), hemiparesis or paraparesis
* Severe vision or hearing problems
Study Plan
Supportive care (golf program)
EXPERIMENTAL
Patients participate in the golf training program composed of group sessions over 1-2 hours with a PGA professional two times per week for ten weeks. Training consists of complimentary/warm up exercises integrated with pelvic floor muscle training, golf instruction, golf practice, and golf play on a Par 3 public golf course. Patients also wear an activity tracker and undergo blood sample collection on the study.
PROCEDURE:
Biospecimen CollectionDescription:
Undergo blood sample collectionPROCEDURE:
DiscussionDescription:
Ancillary studiesOTHER:
Exercise InterventionDescription:
Complete golf related exercisesOTHER:
InterviewDescription:
Ancillary studiesOTHER:
Medical Device Usage and EvaluationDescription:
Wear activity trackerPROCEDURE:
Physical ExaminationDescription:
Ancillary studiesOTHER:
Physical Performance TestingDescription:
Ancillary studiesOTHER:
Questionnaire AdministrationDescription:
Ancillary studiesOTHER:
Recreational TherapyDescription:
Participate in golf program
Outcome Measures
Primary Outcome Measures
Enrollment rate
Participant adherence to the program
Cost of the program
Staff adherence
Program accommodations
Incidence of adverse events
Quality of life scores
Circulating inflammatory biomarker levels
Senior fitness test scores
Gait speed
Balance Confidence
Cognitive function
Participant feedback of the program
Timeline
Last Updated
July 15, 2024Start Date
July 15, 2024Today
January 16, 2025Completion Date ( Estimated )
September 1, 2027
Sponsors of this trial
Lead Sponsor
University of Southern CaliforniaCollaborating Sponsors
National Cancer Institute (NCI)
RECRUITING 
21 - 64 Years